CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0270
+0.000405 (1.52%)
At close: May 18, 2026
CERo Therapeutics Holdings Employees
CERo Therapeutics Holdings had 8 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$11,994,797
Market Cap
1.15M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 8 | 0 | - | 8 | 0 |
| Dec 31, 2024 | 8 | -1 | -11.11% | 8 | 0 |
| Dec 31, 2023 | 9 | - | - | 8 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| International Stem Cell | 33 |
| Evofem Biosciences | 29 |
| Lyra Therapeutics | 27 |
| Windtree Therapeutics | 14 |
| ZyVersa Therapeutics | 7 |
| Abpro Holdings | 3 |
| Avenue Therapeutics | 1 |
CERo Therapeutics Holdings News
- 7 days ago - CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial - GlobeNewsWire
- 4 weeks ago - CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial - GlobeNewsWire
- 7 weeks ago - CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial - GlobeNewsWire
- 2 months ago - Cero Therapeutics issues letter to shareholders - TheFly
- 2 months ago - CERo Therapeutics Provides Shareholder Update - GlobeNewsWire
- 3 months ago - Cero Therapeutics appoints Eric Francois to board of directors - TheFly
- 3 months ago - CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors - GlobeNewsWire
- 3 months ago - Cero Therapeutics to present data from Phase 2 trial of CER-1236 - TheFly